JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
Mirum Pharmaceuticals
MIRM
$5.38B
| $7.69M | ﹤0.01% |
97,386
-2,823
| -3% | -$203K |
2019 Q3
25 quarters
|
|
2852
PUT
Automatic Data Processing
ADP
$102B
| $7.69M | ﹤0.01% |
+29,900
| New | +$7.96M |
2025 Q4
0 quarters
|
|
2853
ArcelorMittal
MT
$48.5B
| $7.69M | ﹤0.01% |
168,721
+129,276
| +328% | +$5.31M |
2013 Q2
50 quarters
|
|
2854
CALL
TJX Companies
TJX
$146B
| $7.68M | ﹤0.01% |
50,000
| – | – |
2021 Q4
16 quarters
|
|
2855
ArcBest
ARCB
$2.96B
| $7.68M | ﹤0.01% |
103,495
-69,182
| -40% | -$4.92M |
2013 Q2
50 quarters
|
|
2856
Reynolds Consumer Products
REYN
$4.7B
| $7.67M | ﹤0.01% |
334,692
+4,558
| +1% | +$110K |
2020 Q2
22 quarters
|
|
2857
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
| $7.63M | ﹤0.01% |
248,417
-1,057,669
| -81% | -$32.5M |
2017 Q1
35 quarters
|
|
2858
CALL
Toll Brothers
TOL
$12.6B
| $7.63M | ﹤0.01% |
56,400
+10,000
| +22% | +$1.36M |
2024 Q2
6 quarters
|
|
|
2859
PUT
Toll Brothers
TOL
$12.6B
| $7.63M | ﹤0.01% |
56,400
+10,000
| +22% | +$1.36M |
2024 Q2
6 quarters
|
|
2860
Blue Bird Corp
BLBD
$1.79B
| $7.6M | ﹤0.01% |
161,629
-764,223
| -83% | -$40M |
2017 Q4
32 quarters
|
|
2861
Indivior Pharmaceuticals
INDV
$4.21B
| $7.58M | ﹤0.01% |
211,208
+3,620
| +2% | +$111K |
2023 Q2
10 quarters
|
|
2862
Cadre Holdings
CDRE
$1.07B
| $7.56M | ﹤0.01% |
185,129
-64,894
| -26% | -$2.7M |
2021 Q4
16 quarters
|
|
2863
CALL
Five Below
FIVE
$12.2B
| $7.53M | ﹤0.01% |
+40,000
| New | +$6.5M |
2025 Q4
0 quarters
|
|
2864
Scholar Rock
SRRK
$5.7B
| $7.52M | ﹤0.01% |
170,773
-543,215
| -76% | -$20.4M |
2018 Q3
29 quarters
|
|
2865
TransAlta
TAC
$3.91B
| $7.52M | ﹤0.01% |
595,012
+494,695
| +493% | +$7.39M |
2014 Q3
45 quarters
|
|
2866
Jack in the Box
JACK
$239M
| $7.52M | ﹤0.01% |
396,673
+7,346
| +2% | +$133K |
2013 Q2
50 quarters
|
|
2867
Blackstone Mortgage Trust
BXMT
$1.84B
| $7.51M | ﹤0.01% |
392,622
-185,822
| -32% | -$3.52M |
2013 Q2
50 quarters
|
|
2868
CALL
GameStop
GME
$12.5B
| $7.51M | ﹤0.01% |
374,000
+34,000
| +10% | +$763K |
2025 Q3
1 quarter
|
|
2869
Tandem Diabetes Care
TNDM
$1.15B
| $7.51M | ﹤0.01% |
341,631
-17,440
| -5% | -$315K |
2018 Q1
31 quarters
|
|
2870
CALL
Vistra
VST
$47B
| $7.5M | ﹤0.01% |
46,500
+42,200
| +981% | +$7.69M |
2024 Q1
7 quarters
|
|
|
UNIT
2871
Uniti Group
UNIT
$1.95B
| $7.49M | ﹤0.01% |
1,068,795
-1,143,083
| -52% | -$7.24M |
2015 Q2
42 quarters
|
|
2872
CRA International
CRAI
$1.07B
| $7.48M | ﹤0.01% |
37,293
-7,338
| -16% | -$1.38M |
2015 Q1
43 quarters
|
|
2873
Pacira BioSciences
PCRX
$1B
| $7.47M | ﹤0.01% |
288,651
-147,547
| -34% | -$3.51M |
2013 Q2
50 quarters
|
|
2874
CALL
Ascendis Pharma A/S
ASND
$15B
| $7.46M | ﹤0.01% |
35,000
-40,100
| -53% | -$8.28M |
2025 Q3
1 quarter
|
|
|
2875
PUT
Ascendis Pharma A/S
ASND
$15B
| $7.46M | ﹤0.01% |
35,000
-15,100
| -30% | -$3.12M |
2025 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.